Roche
FDA awards Roche priority review in HER2-positive breast cancer
October 2, 2017Sales and Marketing Cancer, FDA, Herceptin, Perjeta, Roche, breast cancer, pharma, pharmaceutical
Roche has revealed that its monoclonal antibody Perjeta (pertuzumab) has been awarded priority review by the FDA as an adjuvant …
Roche chalks up Swiss approval for multiple sclerosis drug Ocrevus
September 28, 2017Sales and Marketing Ocrevus, Roche, multiple sclerosis, pharma, pharmaceutical
Roche has announced that its drug Ocrevus (ocrelizumab) has received marketing approval in Switzerland for the treatment of active relapsing …
Roche’s Tecentriq scores approvals in metastatic lung and bladder cancer
September 27, 2017Research and Development, Sales and Marketing Cancer, EMA, EU, European Commission, Roche, bladder cancer, immunotherapy, lung cancer, pharma, tecentriq
It’s good news for Roche as the company’s immunotherapy drug Tecentriq secures approval from the European Commission to be used …
Roche and AbbVie’s leukaemia combo smashes Phase 3 endpoint
September 19, 2017Manufacturing and Production, Research and Development AbbVie, Rituxan, Roche, Venclexta, Venclyxto, leukaemia, pharma, pharmaceutical
Venclexta/Venclyxto (venetoclax), Roche and AbbVie’s oral B-cell lymphoma-2 (BCL-2) inhibitor, successfully met its primary endpoint in Phase 3 trials, providing …
FDA locks down combo immunotherapy trials, Roche added to hold
September 19, 2017Manufacturing and Production, Sales and Marketing Roche, biotech, drugs, immunotherapy, pharma, pharmaceutical, tecentriq
The FDA has moved to ensure that all immunotherapy trials studying PD-1/L1 agents, alongside immunomodulatory medicines in certain blood cancers …
Melanoma treatment: Novartis posts success, Roche stumbles
September 11, 2017Research and Development, Sales and Marketing Novartis, Roche, biotech, drugs, melanoma, pharma, pharmaceutical
In a perfect example of the competitive nature of the pharmaceutical industry, just as one company posted success in one …
FDA approves treatment to counter CAR-T side-effects
August 31, 2017Medical Communications, Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical
On the day that FDA announced the first CAR-T therapy would be given market authorisation, it also announced that a …
Roche receives FDA Priority Review for drug with potted history
August 24, 2017Sales and Marketing Roche, biotech, drugs, emicizumab, pharma, pharmaceutical
Roche, alongside its subsidiary, Genentech, announced that it has received Priority Review for its haemophilia A drug, emicizumab, and that …
Shire and Roche haemophilia spat spills into court
July 10, 2017Sales and Marketing Roche, Shire, haemophilia
Roche released new scientific data at a conference in Berlin regarding its developmental drug in haemophilia, emicizumab, and Shire chose …
Roche haemophilia therapy cuts bleed rate by 87%
June 26, 2017Research and Development, Sales and Marketing Roche, haemophilia
Roche has revealed new data on its investigational haemophilia therapy ACE910 (emicizumab) which shows an 87% reduction in bleed rate …
Novartis receives European biosimilar approval for Roche blockbuster
June 19, 2017Sales and Marketing Novartis, Rituxan, Rixathon, Roche
Sandoz, a division within Novartis, has received European Commission approval for its biosimilar version of Roche’s Rituxan (also known as …
From pipeline to patients: Navigating treatments through the UK system
June 15, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, pipeline
Pharmafocus spoke to Karen Lightning-Jones, Integrated Franchise Leader, Pipeline, to discuss the current UK climate for successfully developing drugs to …
Silence Therapeutics instate new COO
June 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Roche, Silence Therapeutics
Silence Therapeutics, a company focused on developing medicines through the body’s natural mechanism of RNA interference, has appointed a new …
Evidence of tampering with Valium medication in Australia
May 31, 2017Medical Communications, Research and Development Roche, valium
Roche, the supplier of Valium in Australia, had notified the Therapeutic Goods Administration (TGA) that it had discovered evidence of …
The June 2017 issue of Pharmafocus is now live!
May 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Pharmafocus, Roche, Takeda, UK, brexit, data management, market access, neurological disorders
The latest edition of Pharmafocus is available to read online now!
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
